Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 27, 2025, titled "Glenmark Pharmaceuticals receives Establishment Inspection Report (EIR) from U.S. FDA for its Monroe facility".
Press Release Nov 27 2025
Filed with NSE · · 2 pages · English
Release
Glenmark Pharmaceuticals Limited on 6ix
Earlier from Glenmark Pharmaceuticals
- Press Release Nov 25 2025
- Q2FY 2025-26
- Press Release Nov 18 2025
- Press Release Nov 14 2025
- Press Release Nov 10 2025
Later from Glenmark Pharmaceuticals
- Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe
- Glenmark Pharmaceuticals Limited Press Release Dec 11 2025
- Press Release Dec 16 2025
- Glenmark Pharmaceuticals Limited Press Release Dec 23 2025
- Press Release Jan 30 2026
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals